Myoendothelial differentiation of human umbilical cord blood-derived stem cells in ischemic limb tissues

Area of Science:

• Regenerative Medicine
• Stem Cell Biology
• Vascular Biology

Background:

• Human umbilical cord blood (UCB) is rich in endothelial progenitor cells (EPCs) expressing CD34 and CD133.
• Previous research indicated EPCs from cord blood (CB) or peripheral blood (PB) can form endothelial cells and promote angiogenesis.
• The plasticity of these progenitor cells remains an area of active investigation.

Purpose of the Study:

• To investigate the differentiation potential of human cord blood CD34+ cells in vivo and in vitro.
• To determine if CD34+ cells can contribute to both vascular and muscle tissue regeneration.
• To explore the potential of EPCs beyond endothelial cell formation.

Main Methods:

• Freshly isolated human cord blood CD34+ and CD34- cells were injected into ischemic adductor muscles of mice.
• Non-ischemic limbs were also analyzed after CD34+ cell injection.
• In vitro studies involved co-culturing CD34+ cells with mouse myoblasts to assess myogenic conversion.
• Ex vivo expansion of CD34+ cells was performed to evaluate differentiation capacity.

Main Results:

• Injected human cord blood CD34+ cells differentiated into endothelial and skeletal muscle cells in mice.
• Treated ischemic limbs showed increased arteriole density and regenerating muscle fiber density.
• CD34- cells did not promote arteriogenesis or muscle regeneration.
• CD34+ cells enhanced arteriole density in non-ischemic limbs but did not induce muscle formation.
• Both endothelial and myogenic differentiation potential were retained after ex vivo expansion.
• In vitro co-culture confirmed myogenic conversion of CD34+ cells.

Conclusions:

• Human cord blood CD34+ cells possess plasticity, differentiating into both endothelial and skeletal muscle lineages.
• These findings suggest a broader therapeutic potential for CD34+ cells in treating ischemic conditions and muscle injuries.
• The study highlights the capacity of human EPCs to contribute to multiple cell types, expanding their known regenerative capabilities.